An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus

Cited by (690)

Items 401–500 of 690

1. SARS-CoV-2 Neutralization Assays Used in Clinical Trials: A Narrative Review
   Yeqing Sun, Weijin Huang, Hongyu Xiang, Jianhui Nie · 2024 · Vaccines
2. Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS
   Benoît Callendret, Valérie Lorin, Pierre Charneau, Philippe Marianneau, Hugues Contamin, Jean‐Michel Betton, Sylvie van der Werf, Nicolas Escriou · 2007 · Virology
3. Antibody- and Fc-receptor-based therapeutics for malaria
   Jianguo Shi, Richard Stephen McIntosh, Richard J. Pleass · 2005 · Clinical Science
4. Human monoclonal antibodies to West Nile virus identify epitopes on the prM protein
   Amanda E. Calvert, Gavreel Kalantarov, Gwong‐Jen J. Chang, Ilya Trakht, Carol D. Blair, John T. Roehrig · 2010 · Virology
5. Calcio-Herbal Medicine Divya-Swasari-Vati Ameliorates SARS-CoV-2 Spike Protein-Induced Pathological Features and Inflammation in Humanized Zebrafish Model by Moderating IL-6 and TNF-α Cytokines
   Acharya Balkrishna, Sudeep Verma, Siva Kumar Solleti, Lakshmipathi Khandrika, Anurag Varshney · 2020 · Journal of Inflammation Research
6. Exceptionally potent human monoclonal antibodies are effective for prophylaxis and treatment of tetanus in mice
   Marco Pirazzini, Alessandro Grinzato, Davide Corti, Sonia Barbieri, Oneda Leka, Francesca Vallese, Marika Tonellato, Chiara Silacci-Fregni, Luca Piccoli, Eaazhisai Kandiah et al. · 2021 · Journal of Clinical Investigation
7. Human monoclonal IgG selection of Plasmodium falciparum for the expression of placental malaria‐specific variant surface antigens
   J. SOERLI, Lea Klingenberg Barfod, Thomas Lavstsen, Nadia L. Bernasconi, Antonio Lanzavecchia, Lars Hviid · 2009 · Parasite Immunology
8. Therapies for coronaviruses. Part I of II – viral entry inhibitors
   Tommy Richard Sun-wing Tong · 2009 · Expert Opinion on Therapeutic Patents
9. Development of a Human-Murine Chimeric Immunoglobulin M Antibody for Use in the Serological Detection of Human Flavivirus Antibodies
   Brett A. Thibodeaux, John T. Roehrig · 2009 · Clinical and Vaccine Immunology
10. Protection of Mammalian Cells from Severe Acute Respiratory Syndrome Coronavirus Infection by Equine Neutralizing Antibody
    Xiliang Wang, Bing Ni, Xinan Du, Guangyu Zhao, Wenda Gao, Xinfu Shi, Zhang Songle, Liangyan Zhang, Dong Wang, Deyan Luo et al. · 2005 · Antiviral Therapy
11. Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA
    Pinto, Vera V., Ditlev, Sisse B., Jensen, Kamilla E., Resende, Mafalda, Dahlbäck, Madeleine, Andersen, Gorm, Andersen, Pernille, Theander, Thor G., Salanti, Ali, Nielsen, Morten A. · 2011 · PLoS ONE
12. Human antibody technology and the development of antibodies against cytomegalovirus
    Mats Ohlin, Cecilia Söderberg‐Nauclér · 2015 · Molecular Immunology
13. Identification of a Novel Non-desmoglein Autoantigen in Pemphigus Vulgaris
    Giulia Di Lullo, Valentina Calabresi, Feliciana Mariotti, Giovanna Zambruno, Antonio Lanzavecchia, Giovanni Di Zenzo · 2019 · Frontiers in Immunology
14. Characterization of Two Human Monoclonal Antibodies Neutralizing Influenza A H7N9 Viruses
    Jianmin Wang, Zhe Chen, Linlin Bao, Weijia Zhang, Ying Xue, Xinghuo Pang, Xi Zhang, Chuan Qin, Qi Jin · 2015 · Journal of Virology
15. Beneficial effect of T follicular helper cells on antibody class switching of B cells in prostate cancer
    Jiufeng Tan, Xuefei Jin, Rui Zhao, Xin Wei, Yan Liu, Xiangbo Kong · 2014 · Oncology Reports
16. Analysis of Human Monoclonal Antibodies Generated by Dengue Virus-Specific Memory B Cells
    Heather Friberg, Smita Jaiswal, Kim West, Marvin O’Ketch, Alan L. Rothman, Anuja Mathew · 2012 · Viral Immunology
17. Antiviral Vaccines: Challenges and Advances
    Ali H. Ellebedy, Rafi Ahmed · 2016 · Elsevier eBooks
18. Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy
    Seung Hyun Kang, Chang‐Han Lee · 2021 · Biotechnology and Bioprocess Engineering
19. Exploring the Native Human Antibody Repertoire to Create Antiviral Therapeutics
    Scott K. Dessain, Sharad P. Adekar, Jody D. Berry · 2007 · Current topics in microbiology and immunology
20. Cell activation by CpG ODN leads to improved electrofusion in hybridoma production
    Mieko Kato, Eriko Sasamori, Tomoki Chiba, Yoshiro Hanyu · 2011 · Journal of Immunological Methods
21. Assessment of the effect of TLR7/8, TLR9 agonists and CD40 ligand on the transformation efficiency of Epstein-Barr virus in human B lymphocytes by limiting dilution assay
    Vahid Younesi, Forough Golsaz‐Shirazi, Ali Memarian, Amir Amanzadeh, Mahmood Jeddi‐Tehrani, Fazel Shokri · 2013 · Cytotechnology
22. Evaluation of Antigen-Conjugated Fluorescent Beads to Identify Antigen-Specific B Cells
    Isabel Corrêa, Kristina M. Ilieva, Silvia Crescioli, Sara Lombardi, Mariangela Figini, Anthony Cheung, James F. Spicer, Andrew N.J. Tutt, Frank Oliver Nestle, Panagiotis Karagiannis et al. · 2018 · Frontiers in Immunology
23. Convalescent Plasma against COVID-19: A Broad-Spectrum Therapeutic Approach for Emerging Infectious Diseases
    Marijn Thijssen, Timothy Devos, Hanieh‐Sadat Ejtahed, Samad Amini‐Bavil‐Olyaee, Ali Akbar Pourfathollah, Mahmoud Reza Pourkarim · 2020 · Microorganisms
24. Generation and Characterization of a Nanobody Against SARS-CoV
    Jiangfan Li, Lei He, Yong‐Qiang Deng, Shuhui Qi, Yuehong Chen, Xiaolu Zhang, Shixiong Hu, Ruiwen Fan, Guangyu Zhao, Cheng‐Feng Qin · 2021 · Virologica Sinica
25. High throughput HIV-1 microneutralization assay
    Nicole A. Doria‐Rose, Nicole A. Doria‐Rose, Robert T. Bailer, Mark K. Louder, Chien-Li Lin, Ellen Turk, Leo Laub, Nancy S. Longo, Mark Connors, John R. Mascola · 2013 · Protocol Exchange
26. Human Antibody Repertoires
    Per‐Johan Meijer, Lars Søegaard Nielsen, Johan Lantto, Allan D. Jensen · 2008 · Methods in molecular biology
27. VII International Symposium on Respiratory Viral Infections
    Alison Bermingham, Kelly J. Henrickson, Frederick G. Hayden, Maria Cristina Fleischmann Alves Zambon · 2007 · Antiviral Therapy
28. Efficient Qualitative and Quantitative Determination of Antigen-induced Immune Responses
    Danlin Yang, Lee Frego, Marcio O. Lasaro, Kristopher Truncali, Rachel Kroe‐Barrett, Sanjaya Singh · 2016 · Journal of Biological Chemistry
29. Current Review of Monoclonal Antibody Therapeutics in Small Animal Medicine
    Jianzhong Wang, Xueying Zhou, Sara T. Elazab, Jian V. Huang, Walter H. Hsu · 2025 · Animals
30. Enhanced outgrowth of EBV-transformed chronic lymphocytic leukemia B cells mediated by coculture with macrophage feeder cells
    Kwan‐Ki Hwang, Xi Chen, Daniel M. Kozink, Marietta M Gustilo, Dawn J. Marshall, John F. Whitesides, Hua‐Xin Liao, Rosa Catera, Charles C. Chu, Xiao‐Jie Yan et al. · 2011 · Blood
31. Convalescent plasma treatment for COVID‐19: Tempering expectations with the influenza experience
    Kanta Subbarao, Francesca L. Mordant, Rajeev Rudraraju · 2020 · European Journal of Immunology
32. Recent advances in the study of human antibody responses to influenza virus using optimized human hybridoma approaches
    James E. Crowe · 2009 · Vaccine
33. Accessing the human repertoire for broadly neutralizing HIV antibodies
    Philip W. Hammond · 2010 · mAbs
34. Human monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1
    Zhongyu Zhu, Ponraj Prabakaran, Weizao Chen, Christopher C. Broder, Rui Gong, Dimiter Stanchev Dimitrov · 2013 · Virologica Sinica
35. Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2
    Jiajia Xie, Chengchao Ding, Jun He, Yuqing Zhang, Shuangshuang Ni, Xiangyu Zhang, Qingqing Chen, Jing Wang, Lina Huang, Hongliang He et al. · 2021 · Frontiers in Immunology
36. Renewal of EBV-hybridoma method: Efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells
    Akira Ainai, Takuo Kawase, Akari Ida, Yoshitaka Maeda, Hiroyoshi Ohba, Yoshihisa Ikeda, Hiroko Sato, Motohide Takahashi, Joe Chiba · 2007 · Human Antibodies
37. Animal models and antibody assays for evaluating candidate SARS vaccines: Summary of a technical meeting 25–26 August 2005, London, UK
    Anjeanette Roberts, John Wood, Kanta Subbarao, Morag Ferguson, David Wood, Thomas Cherian · 2006 · Vaccine
38. Cellular and Molecular Immunology Approaches for the Development of Immunotherapies against the New Coronavirus (SARS‐CoV‐2): Challenges to Near‐Future Breakthroughs
    Juliana Gil Melgaço, Danielle Brito e Cunha, Tamiris Azamor, Andréa Marques Vieira da Silva, Luciana Neves Tubarão, Rafael Braga Gonçalves, Robson Q. Monteiro, Sotiris Missailidis, Patrícia Neves, Ana Paula Dinis Ano Bom · 2020 · Journal of Immunology Research
39. Induction of Interferon-Stimulated Genes on the IL-4 Response Axis by Epstein-Barr Virus Infected Human B Cells; Relevance to Cellular Transformation
    Darren Smith, Rosemary J. Tierney, Wenbin Wei, Martina Vockerodt, Paul Gerard Murray, Ciaran B. J. Woodman, Martin Rowe · 2013 · PLoS ONE
40. Evaluation of the safety, immunogenicity and pharmacokinetics of equine anti-SARS–CoV F(ab′)2 in macaque
    Yunsheng Xu, Zhengcai Jia, Liyun Zhou, Li Wang, Jintao Li, Yunfei Liang, Tingting Zhao, Bing Ni, Yuzhang Wu · 2007 · International Immunopharmacology
41. Ro52 autoantibodies arise from self-reactive progenitors in a mother of a child with neonatal lupus
    Joanne H. Reed, Miroslaw K. Górny, Liuzhe Li, Timothy J. Cardozo, Jill P. Buyon, Robert M. Clancy · 2017 · Journal of Autoimmunity
42. Some opportunities for immunotherapy in coronavirus infection
    В. С. Смирнов, Арег А. Тотолян · 2020 · Russian Journal of Infection and Immunity
43. Complement inhibition: A possible therapeutic approach in the fight against Covid‐19
    Niloofar Deravi, Elahe Ahsan, Mobina Fathi, Parastoo Hosseini, Shirin Yaghoobpoor, Ramin Lotfi, Atieh Pourbagheri‐Sigaroodi, Davood Bashash · 2021 · Reviews in Medical Virology
44. Characterization of Neutralizing Profiles in HIV-1 Infected Patients from whom the HJ16, HGN194 and HK20 mAbs were Obtained
    Sunita S. Balla-Jhagjhoorsingh, Betty Willems, Liesbeth Heyndrickx, Leo Heyndríckx, Katleen Vereecken, Wouter Janssens, Michael S. Seaman, Davide Corti, Antonio Lanzavecchia, David A. Davis et al. · 2011 · PLoS ONE
45. The development of neutralizing antibodies against SARS-CoV-2 and their common features
    Liu Daisy Liu, Chaoyang Lian, Leng-Siew Yeap, Fei‐Long Meng · 2020 · Journal of Molecular Cell Biology
46. Coronavirus disease 2019 and the revival of passive immunization: Antibody therapy for inhibiting severe acute respiratory syndrome coronavirus 2 and preventing host cell infection: IUPHAR review 31
    Francesca Levi‐Schaffer, Ario de Marco · 2021 · British Journal of Pharmacology
47. Novel monoclonal antibody-based therapies: implications for the treatment and prevention of HCMV disease
    Marcos Nuévalos, Estéfani García‐Ríos, Francisco J. Mancebo, Clara Martín-Martín, Pilar Pérez‐Romero · 2023 · Trends in Microbiology
48. Generation of a cost-effective cell line for support of high-throughput isolation of primary human B cells and monoclonal neutralizing antibodies
    Rachael E. Whaley, Sarah Ameny, Tanvi Arkatkar, Aaron M. Seese, Abigail Wall, Iram Khan, Joseph J. Carter, Erin M. Scherer, David J. Rawlings, Denise A. Galloway et al. · 2020 · Journal of Immunological Methods
49. Immunotherapy of Viral Infections
    Nagendra R. Hegde, Pavuluri Panduranga Rao, Jagadeesh Bayry, Srini V. Kaveri · 2009 · Immunotherapy
50. Screening of Random Peptide Library of Hemagglutinin from Pandemic 2009 A(H1N1) Influenza Virus Reveals Unexpected Antigenically Important Regions
    Wanghui Xu, Lu Han, Zhanglin Lin · 2011 · PLoS ONE
51. A flow cytometry-based strategy to identify and express IgM from VH1-69+ clonal peripheral B cells
    Edgar D. Charles, Michael Orloff, Lynn B. Dustin · 2010 · Journal of Immunological Methods
52. Intrathecal B Cells in MS Have Significantly Greater Lymphangiogenic Potential Compared to B Cells Derived From Non-MS Subjects
    Jason Stein, Quangang Xu, Kayla C. Jackson, Elena Romm, Simone C. Wuest, Peter F. Kosa, Tianxia Wu, Bibiana Bielekova · 2018 · Frontiers in Neurology
53. Human monoclonal antibodies for discovery, therapy, and vaccine acceleration
    Emanuele Andreano, Anja Seubert, Rino Rappuoli · 2019 · Current Opinion in Immunology
54. What are the drugs having potential against COVID-19?
    Kaan Küçükoğlu, Nagihan Faydalı, Dilek Bul · 2020 · Medicinal Chemistry Research
55. Generation of “LYmph Node Derived Antibody Libraries” (LYNDAL) for selecting fully human antibody fragments with therapeutic potential
    Philipp Diebolder, Armin Keller, Stephanie Haase, Anne Schlegelmilch, Jonathan D. Kiefer, Tamana Karimi, Tobias Weber, Gerhard Moldenhauer, Roland Kehm, Anna Maria Eis‐Hübinger et al. · 2013 · mAbs
56. Repertoire of antibodies against type 1 poliovirus in human sera
    Gennady V. Rezapkin, Alexander Neverov, Elena A. Cherkasova, Emmanuel J. Vidor, Andrey G. Sarafanov, Diana V. Kouiavskaia, Eugenia M. Dragunsky, Konstantin Chumakov · 2010 · Journal of Virological Methods
57. Immunosuppressive human anti‐lymphocyte autoantibodies specific for the type 1 sphingosine 1‐phosphate receptor
    Jia‐Jun Liao, Mei‐Chuan Huang, Katharine Fast, Katherine E. Gundling, Mahesh Yadav, James R. Van Brocklyn, Matthias R. Wabl, Edward J. Goetzl · 2009 · The FASEB Journal
58. Updates on the Production of Therapeutic Antibodies Using Human Hybridoma Technique
    Xenia A. Glukhova, Olga V. Prusakova, Julia A. Trizna, M M Zaripov, G. V. Afanas’eva, Anatoly S. Glukhov, Р. А. Полтавцева, Ivanov Aa, Marco Ávila-Rodriguez, George Emilio Barreto et al. · 2016 · Current Pharmaceutical Design
59. Genomic Diversity and Evolution, Diagnosis, Prevention, and Therapeutics of the Pandemic COVID-19 Disease
    M. Nazmul Hoque, Abed Chaudhury, Md. Abdul Mannan Akanda, M. Anwar Hossain, Tofazzal Islam · 2020 · Preprints.org
60. Correction: In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection
    Ruklanthi de Alwis, Martina Beltramello, William B. Messer, Soila Sukupolvi-Petty, Wahala M. P. B. Wahala, Annette Kraus, Nicholas P. Olivarez, Quang Khuong Pham, James Brian, Wen-Yang Tsai et al. · 2011 · PLoS neglected tropical diseases
61. Dissecting the intricacies of human antibody responses to SARS-CoV-1 and SARS-CoV-2 infection
    Ruoke Wang, Yang Han, Rui Zhang, Jiayi Zhu, Xuanyu Nan, Yaping Liu, Ziqing Yang, Bini Zhou, Jinfang Yu, Zichun Lin et al. · 2023 · Immunity
62. Innate stimulation of B cells ex vivo enhances antibody secretion and identifies tumour-reactive antibodies from cancer patients
    Panagiotis Karagiannis, Isabel Corrêa, Jitesh Chauhan, Anthony Cheung, Diana Dominguez-Rodriguez, Manuela Terranova-Barberio, R. J. C. Harris, Silvia Crescioli, James F. Spicer, Carsten Bokemeyer et al. · 2021 · Clinical & Experimental Immunology
63. Broad Reactivity Single Domain Antibodies against Influenza Virus and Their Applications to Vaccine Potency Testing and Immunotherapy
    Andrew Tung Yep, Yasu Takeuchi, Othmar G. Engelhardt, Simon E. Hufton · 2021 · Biomolecules
64. Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies
    Scott Alan Smith, James E. Crowe · 2015 · ASM Press eBooks
65. Antibody Binding Site Mapping of SARS-CoV Spike Protein Receptor-Binding Domain by a Combination of Yeast Surface Display and Phage Peptide Library Screening
    Xiaoping Zhang, Jingxue Wang, Kun Wen, Zhirong Mou, Liyun Zou, Xiaoyan Che, Bing Ni, Yuzhang Wu · 2009 · Viral Immunology
66. The Cloning and Expression of Human Monoclonal Antibodies: Implications for Allergen Immunotherapy
    Louisa Katherine James · 2016 · Current Allergy and Asthma Reports
67. Crosstalk Between Covid-19 and Associated Neurological Disorders: A Review
    Anu Kunnath Ramachandran, Subham Das, Alex Joseph · 2021 · Current Neuropharmacology
68. Sea Urchin Pigments as Potential Therapeutic Agents Against the Spike Protein of SARS-CoV-2 Based on in Silico Analysis
    Elena Susana Barbieri, Tamara Rubilar, Ayelén Gázquez, Marisa Gladis Avaro, Erina Noé Seiler, Mercedes Vera-Piombo, Agustín Gittardi, Florencia Chaar, Jimena Pía Fernández, Lucas Sepulveda · 2020 · ChemRxiv
69. Identification of 22 N-glycosites on Spike Glycoprotein of SARS-CoV-2 and Accessible Surface Glycopeptide Motifs: Implications on Vaccination and Antibody Therapeutics
    Dapeng Zhou, Ruibing Qi, Wen Zhang, Xiaoxu Tian, Chao Peng · 2020 · Preprints.org
70. Quantitative Mutation Analysis of Genes and Proteins of Major SARS-CoV-2 Variants of Concern and Interest
    Fengyi Liang · 2023 · Viruses
71. Emerging studies of human HIV-specific antibody repertoires
    Mark Daniel Hicar, Spyros A. Kalams, Paul W. Spearman, James E. Crowe · 2010 · Vaccine
72. Production, Novel Assay Development and Clinical Applications of Monoclonal Antibodies
    Pieranna Chiarella · 2011 · Recent Patents on Anti-Cancer Drug Discovery
73. Production of an Anti-Severe Acute Respiratory Syndrome (SARS) Coronavirus Human Monoclonal Antibody Fab Fragment by Using a Combinatorial Immunoglobulin Gene Library Derived from Patients Who Recovered from SARS
    Jinye Liu, Hongxia Shao, Yan-Lin Tao, Bin Yang, Lisheng Qian, Xiaoli Yang, Brian B. Cao, Gengxi Hu, Hiroshi Tachibana, Xunjia Cheng · 2006 · Clinical and Vaccine Immunology
74. Generation of anti-NAG-2 mAb from patients' memory B cells: implications for a novel therapeutic strategy in systemic sclerosis
    Elisabetta Traggiai, Claudio Lunardi, Caterina Bason, Marzia Dolcino, Elisa Tinazzi, Roberto Corrocher, Antonio Puccetti · 2010 · International Immunology
75. Human B Cell Immortalization for Monoclonal Antibody Production
    Joyce S Hui‐Yuen, Siva Rama Krishna Koganti, Sumita Bhaduri‐McIntosh · 2014 · Methods in molecular biology
76. Profiling the IgOme: Meeting the challenge
    Yael Weiss-Ottolenghi, Jonathan M. Gershoni · 2013 · FEBS Letters
77. Isolation of monoclonal antibodies from anti-synthetase syndrome patients and affinity maturation by recombination of independent somatic variants
    Luke Burman, Yeeting Esther Chong, Sherie Duncan, Anders Klaus, Kaitlyn Rauch, Kristina Hamel, Karine Hervé, Stephanie Pfaffen, David W. Collins, Kevin A. Heyries et al. · 2020 · mAbs
78. SARS Coronavirus Anti-Infectives
    Tommy Richard Sun-wing Tong · 2006 · Recent Patents on Anti-Infective Drug Discovery
79. Technologies for Monoclonal Antibody Discovery and Development
    Kyung Ho Han, Yi‐Chuan Li, Rabia Parveen, Srimathi Venkataraman, Chih‐Wei Lin · 2025 · International Journal of Molecular Sciences
80. Human hybridoma technology
    Miroslaw K. Górny · 2012 · Antibody Technology Journal
81. Prophylactic Activity of Orally Administered FliD-Reactive Monoclonal SIgA Against Campylobacter Infection
    Lisa Perruzza, Stefano Jaconi, Gloria Lombardo, Debora Pinna, Francesco Strati, Diego Morone, Frauke Seehusen, Yue Hu, Sakshi Bajoria, Jian Xiong et al. · 2020 · Frontiers in Immunology
82. Rapid isolation of pan-neutralizing antibodies against Omicron variants from convalescent individuals infected with SARS-CoV-2
    Peng Yu, Jingping Ran, Ruiqi Yang, Hang Zhu, Lu Song, Yuzhang Wu, Tingting Zhao, Tian-Chen Xiong · 2024 · Frontiers in Immunology
83. New technologies in therapeutic antibody development: The next frontier for treating infectious diseases
    Sheila Marie Keating, Brett Higgins · 2024 · Antiviral Research
84. Defective germinal center selection results in persistence of self-reactive B cells from the primary to the secondary repertoire in Primary Antiphospholipid Syndrome
    Yannick Dieudonné, Raquel Lorenzetti, Julien Rottura, Iga Janowska, Quentin Frenger, Léa Jacquel, Olivier Vollmer, Francesco Carbone, Chengsong Zhu, Marine Luka et al. · 2024 · Nature Communications
85. Immortalization of Human B Cells: Analysis of B Cell Repertoire and Production of Human Monoclonal Antibodies
    Elisabetta Traggiai · 2012 · Methods in molecular biology
86. A Novel Chimeric Anti-PA Neutralizing Antibody for Postexposure Prophylaxis and Treatment of Anthrax
    Siping Xiong, Qi Tang, Xudong Liang, Tingting Zhou, Jin Yang, Peng Liu, Ya Chen, Changjun Wang, Zhenqing Feng, Jin Zhu · 2015 · Scientific Reports
87. Brief introduction of current technologies in isolation of broadly neutralizing HIV-1 antibodies
    Zehua Sun, Lixin Yan, Jiansong Tang, Qian Qian, Jerica L. Lenberg, Dandan Zhu, Wan Liu, Kao Wu, Yilin Wang, Shiqiang Lu · 2017 · Virus Research
88. Altered gene expression in lymphoblastoid cell lines after subculture
    Michihiro Toritsuka, Manabu Makinodan, Takahira Yamauchi, Yasunori Yamashita, Daisuke Ikawa, Takashi Komori, Sohei Kimoto, Kaori Hamano-Iwasa, Hideo Matsuzaki, Taishiro Kishimoto · 2018 · In Vitro Cellular & Developmental Biology - Animal
89. Severe acute respiratory syndrome (SARS)
    Susan Marie Poutanen, Donald E. Low · 2006 · CRC Press eBooks
90. Generation of Human B-Cell Lines Dependent on CD40-Ligation and Interleukin-4
    Jacques Banchereau · 2015 · Frontiers in Immunology
91. Detection of SARS‐CoV‐2‐specific memory B cells to delineate long‐term COVID‐19 immunity
    Constantin J. Thieme, Mohamed Abou‐El‐Enein, Enrico Fritsche, Moritz Anft, Krystallenia Paniskaki, Sarah Skrzypczyk, Adrian Doevelaar, Magdi Elsallab, Nicola R. Brindle, Arturo Blazquez‐Navarro et al. · 2021 · Allergy
92. Antibody Therapy: From Diphtheria to Cancer, COVID-19, and Beyond
    Deepak Kumar, Sulgey Gauthami, Jagadeesh Bayry, Srini V. Kaveri, Nagendra R. Hegde · 2021 · Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
93. A Human Neutralizing Antibody against a Conformational Epitope Shared by Oligomeric Sars S1 Protein
    Jinzhu Duan, Xin Ji, Jing Feng, Wei Han, Pan‐He Zhang, Wu‐Chun Cao, Xueming Guo, Qi Cai, Dongling Yang, Gang Jin et al. · 2006 · Antiviral Therapy
94. SARS-CoV-2 neutralizing antibody development strategies
    Bertan Koray Balcıoğlu, Melis DENİZCİ ÖNCÜ, Hasan Ümit Öztürk, Fatıma Yücel, Filiz Kaya, Müge Serhatlı, Hivda Ülbeği Polat, Şaban Teki̇n, Aylin Özdemir Bahadır · 2020 · TURKISH JOURNAL OF BIOLOGY
95. DRPADC: A novel drug repositioning algorithm predicting adaptive drugs for COVID-19
    Guobo Xie, Haojie Xu, Jianming Li, Guosheng Gu, Yuping Sun, Zhiyi Lin, Yinting Zhu, Weiming Wang, Youfu Wang, Jiang Shao · 2022 · Computers & Chemical Engineering
96. A fully human neutralizing monoclonal antibody targeting a highly conserved epitope of the human cytomegalovirus glycoprotein B
    Miwa Okamoto, Rika Kurino, Ryu Miura, Kenzo Takada · 2023 · PLoS ONE
97. The Research Progress on Immortalization of Human B Cells
    Huiting Xu, Xinxin Xiang, Weizhe Ding, Dong Wei, Yihong Hu · 2023 · Microorganisms
98. Antibodies, epicenter of SARS-CoV-2 immunology
    Simone Pecetta, Mariagrazia Pizza, Claudia Sala, Emanuele Andreano, Piero Pileri, Marco Troisi, Elisa Pantano, Noemi Manganaro, Rino Rappuoli · 2021 · Cell Death and Differentiation
99. The Severe Acute Respiratory Syndrome
    Kwok‐Yung Yuen, Samson S. Y. Wong, Malik J. S. Peiris · 2006 · Springer eBooks
100. Cell-Based Platform for Antigen Testing and Its Application for SARS-CoV-2 Infection
     Marvin A. Ssemadaali, Sherri L. Newmyer, Harikrishnan Radhakrishnan, Juan Arredondo, Harold S. Javitz, Satya Dandekar, Parijat Bhatnagar · 2022 · Microbiology Spectrum